Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The assessment of myocardial ischemia represents a cornerstone in our approach to coronary artery disease. Indeed many of the clinical decisions we make revolve around the results of stress testing, the assessment of coronary luminal stenoses and, more recently, fractional flow reserve measurements. Whilst the assessment of ischemia is often useful with respect to diagnosis and its treatment important in terms of symptom relief, whether ischemia directly leads to adverse cardiovascular outcomes, in particular myocardial infarction, is much more controversial. Indeed this is one of the key questions facing cardiology practice today and the focus of an ongoing multimillion-dollar study, the ISCHEMIA trial. In this editorial the authors examine some of the underlying evidence and ask the question: is ischemia itself really bad for you?

Original publication




Journal article


Expert rev cardiovasc ther

Publication Date





131 - 134


Coronary Artery Disease, Decision Making, Exercise Test, Humans, Myocardial Infarction, Myocardial Ischemia